Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 12/20 | 0.63 |
| ▸ | MTNR1B | P49286 | 12/20 | 0.63 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.46 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31332052 | 1.00 | MTNR1A (0.63) | MTNR1AMTNR1BTAAR1MCHR1HTR2A | |
| Hydrochloric Acid SCHEMBL20561917 | 0.98 | MTNR1A (0.61) | MTNR1AMTNR1BTAAR1MCHR1HTR2A | |
| SCHEMBL14400281 | 0.81 | MTNR1A (0.61) | MTNR1AMTNR1BMCHR1 | |
| SCHEMBL31331960 | 0.81 | MTNR1A (0.58) | MTNR1AMTNR1BTAAR1HTR2A | |
| SCHEMBL30003079 | 0.80 | MTNR1A (0.56) | MTNR1AMTNR1BMCHR1 | |
| SCHEMBL28892601 | 0.80 | MTNR1A (0.56) | MTNR1AMTNR1BMCHR1 | |
| Hydrochloric Acid SCHEMBL20562650 | 0.77 | TAAR1 (0.41) | MTNR1AMTNR1BTAAR1HTR2A | |
| SCHEMBL3405870 | 0.76 | MTNR1A (0.52) | MTNR1AMTNR1B | |
| SCHEMBL20563275 | 0.76 | MTNR1A (0.81) | MTNR1AMTNR1B | |
| SCHEMBL591651 | 0.75 | KCNH2 (0.48) | MTNR1AMTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250333371-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2025-10-30 | — | — | US | disclosed |
| EP-4532462-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2025-04-09 | — | — | EP | disclosed |
| WO-2023230649-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2023-12-07 | — | — | WO | disclosed |
| WO-2023230649-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2023-12-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250333371-A1 | COMPOUNDS | SDHA, PYGB, SLC18A2 | MTNR1A 1247/4885MTNR1B 757/4885TAAR1 647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.